New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota

by Marina Lorente-Picón, Ariadna Laguna
Published 2021-03-01

Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows

by Helena Xicoy, Núria Peñuelas, Miquel Vila, Ariadna Laguna
Published 2019-10-01

Serum metabolic biomarkers for synucleinopathy conversion in isolated REM sleep behavior disorder

by Ariadna Laguna, Helena Xicoy, Eduardo Tolosa, Mònica Serradell, Dolores Vilas, Carles Gaig, Manel Fernández, Oscar Yanes, Joan Santamaria, Núria Amigó, Alex Iranzo, Miquel Vila
Published 2021-05-01

Sox6 and Otx2 Control the Specification of Substantia Nigra and Ventral Tegmental Area Dopamine Neurons

by Lia Panman, Maria Papathanou, Ariadna Laguna, Tony Oosterveen, Nikolaos Volakakis, Dario Acampora, Idha Kurtsdotter, Takashi Yoshitake, Jan Kehr, Eliza Joodmardi, Jonas Muhr, Antonio Simeone, Johan Ericson, Thomas Perlmann
Published 2014-08-01

Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis

by Iria Carballo-Carbajal, Ariadna Laguna, Jordi Romero-Giménez, Thais Cuadros, Jordi Bové, Marta Martinez-Vicente, Annabelle Parent, Marta Gonzalez-Sepulveda, Núria Peñuelas, Albert Torra, Beatriz Rodríguez-Galván, Andrea Ballabio, Takafumi Hasegawa, Analía Bortolozzi, Ellen Gelpi, Miquel Vila
Published 2019-03-01